<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zheng S</submitter><funding>Project of Anhui Rural Revitalization of Traditional Chinese Medicine Industry Collaborative Technology Service Center</funding><funding>West Anhui University High-Level Talent Research Start-up Funding</funding><funding>Provincial Level Nature Science Foundation of Anhui Education Department</funding><funding>Anhui Scientific Research and Innovation Team of Quality Evaluation and Improvement of Traditional Chinese Medicine</funding><pagination>e34</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12329059</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>26(4)</volume><pubmed_abstract>&lt;h4>Importance&lt;/h4>Hyperuricemia (HUA) is a major metabolic disorder in poultry, leading to gout and kidney damage, which affects farm productivity. Accordingly, understanding the pharmacodynamics (PD) and pharmacokinetics (PK) of uric acid-lowering drugs is essential for improving the treatment strategies in poultry.&lt;h4>Objective&lt;/h4>This study examined the PD and PK characteristics of allopurinol and benzbromarone, two uric acid-lowering drugs, in a quail model of HUA.&lt;h4>Methods&lt;/h4>A hyperuricemic quail model was established using a high-purine diet. Allopurinol and benzbromarone were administered orally. Blood samples were taken and analyzed for the drug concentrations using high-performance liquid chromatography. Pathological examinations were conducted to assess kidney damage.&lt;h4>Re</pubmed_abstract><journal>Journal of veterinary science</journal><pubmed_title>Comparison of pharmacokinetic and pharmacodynamic properties of allopurinol and benzbromarone in a quail model of hyperuricemia.</pubmed_title><pmcid>PMC12329059</pmcid><funding_grant_id>GXXT-2022-079</funding_grant_id><funding_grant_id>2022AH010090</funding_grant_id><funding_grant_id>00701092394</funding_grant_id><funding_grant_id>2022AH051676</funding_grant_id><pubmed_authors>Chen N</pubmed_authors><pubmed_authors>Bu Y</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Zheng S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Comparison of pharmacokinetic and pharmacodynamic properties of allopurinol and benzbromarone in a quail model of hyperuricemia.</name><description>&lt;h4>Importance&lt;/h4>Hyperuricemia (HUA) is a major metabolic disorder in poultry, leading to gout and kidney damage, which affects farm productivity. Accordingly, understanding the pharmacodynamics (PD) and pharmacokinetics (PK) of uric acid-lowering drugs is essential for improving the treatment strategies in poultry.&lt;h4>Objective&lt;/h4>This study examined the PD and PK characteristics of allopurinol and benzbromarone, two uric acid-lowering drugs, in a quail model of HUA.&lt;h4>Methods&lt;/h4>A hyperuricemic quail model was established using a high-purine diet. Allopurinol and benzbromarone were administered orally. Blood samples were taken and analyzed for the drug concentrations using high-performance liquid chromatography. Pathological examinations were conducted to assess kidney damage.&lt;h4>Re</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jul</publication><modification>2026-05-02T02:48:43.921Z</modification><creation>2026-04-07T17:34:45.855Z</creation></dates><accession>S-EPMC12329059</accession><cross_references><pubmed>40765224</pubmed><doi>10.4142/jvs.24313</doi></cross_references></HashMap>